Results of the PRECISION study: Could an answer be given to the question of how safe coxibs versus traditional NSAIDs are in treating patients at high risk for cardiovascular events?
https://doi.org/10.14412/1996-7012-2017-3-129-131
Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the most prescribed drugs worldwide and, like any medication, can cause adverse drug reactions. Since NSAIDs belonging to the group of coxibs, are quite commonly used in clinical practice now, the study of the safety of this class of drugs is given the highest priority. The paper analyzes a largest-scale PRECISION study of the safety of NSAIDs, the aim of which was to assess the cardiovascular safety of celecoxib versus that of ibuprofen and naproxen in patients with osteoarthritis and rheumatoid arthritis
About the Author
E. V. Dovgan
Smolensk Regional Clinical Hospital
Russian Federation
27, Gagarin Prospect, Smolensk 214018
Russian Federation
27, Gagarin Prospect, Smolensk 214018
References
1. Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med. 2016 Dec 29;375(26):2519-29. doi: 10.1056/NEJMoa1611593. Epub 2016 Nov 13.
2. Grigoriou A, Ibrahim F, Chaabo K, et al. Cardiovascular risk with NSAIDs in rheumatoid arthritis: an analysis using routinely collected data. Rheumatology (Oxford). 2016 Apr;55(4): 763-4. doi: 10.1093/rheumatology/kev386. Epub 2015 Nov 24.
3. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med. 2000 Nov 23;343(21):1520-8.
4. Patrono C, Baigent C. Coxibs, Traditional NSAIDs, and Cardiovascular Safety Post- PRECISION: What We Thought We Knew Then and What We Think We Know Now. Clin Pharmacol Ther. 2017 Aug;102(2):238-245. doi: 10.1002/cpt.696. Epub 2017 May 26.
5. Solomon SD, McMurray JJ, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005 Mar 17;352(11): 1071-80. Epub 2005 Feb 15.
6. Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006 Jun 3;332(7553): 1302-8.
7. Patrono C, Baigent C. Nonsteroidal anti-inflammatory drugs and the heart. Circulation. 2014 Feb 25;129(8):907-16. doi: 10.1161/CIRCULATIONAHA.113.004480.
8. FitzGerald GA. Imprecision: Limitations to Interpretation of a Large Randomized Clinical Trial. Circulation. 2017 Jan 10;135(2):113-115. doi: 10.1161/CIRCULATIONAHA.116.026324. Epub 2016 Nov 13.
9. Schuijt MP, Huntjens-Fleuren HW, de Metz M, Vollaard EJ. The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers. Br J Pharmacol. 2009 Jul;157(6):931-4. doi: 10.1111/j.1476-5381.2009.00243.x. Epub 2009 May 19.
10. FDA. Information for Healthcare Professionals: Concomitant Use of Ibuprofen and Aspirin. 2006. https://www.fda.gov/Drugs/DrugSafety/ucm125222.htm
11. Каратеев АЕ, Насонов ЕЛ, Яхно НН. Клинические рекомендации «Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике». Современная ревматология. 2015,9(1):4-23. [Karateev AE, Nasonov EL, Yakhno NN. Clinical guidelines «Rational use of nonsteroidal antiinflammatory drugs (NSAIDs) in clinical practice». Sovremennaya revmatologiya = Modern Rheumatology Journal. 2015,9(1):4-23. (In Russ.)]. doi: 10.14412/1996-7012-2015-1-4-23
Review
For citations:
Dovgan EV. Results of the PRECISION study: Could an answer be given to the question of how safe coxibs versus traditional NSAIDs are in treating patients at high risk for cardiovascular events? Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2017;11(3):129-131. (In Russ.) https://doi.org/10.14412/1996-7012-2017-3-129-131
Views:
1104
Email this article 